ArticleFrontiers in medicine2025
Predictive value of the stone-free rate after percutaneous nephrolithotomy based on multiple machine learning models.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Can AI and predictive models accurately predict stone-free status? a systematic review and meta-analysis.The Canadian journal of urology · 2026Pooled it
- Development and internal validation of a preoperative score for predicting postoperative residual stone after mini-percutaneous nephrolithotomy.World journal of urology · 2026Article
- Evaluation of explainable machine learning models for predicting mid-term stone recurrence after percutaneous nephrolithotomy: a retrospective observational cohort study.International urology and nephrology · 2026Observational
- Exploring key factors affecting stone retention rates in percutaneous nephrolithotomy from a three-dimensional structural perspective: a retrospective study.Quantitative imaging in medicine and surgery · 2026Article
- Forecasting Stone-Free Status Following Percutaneous Nephrolithotomy Utilizing Explainable Machine Learning.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aimed to develop three types of machine learning (ML) models based on gradient boosting decision tree (GBDT), random forest (RF), and extreme gradient boosting (XGBoost) to explore their predictive value for the stone-free rate after percutaneous nephrolithotomy (PCNL). Patients and methods: A retrospective analysis was conducted on 160 patients who underwent PCNL. The patients were randomly divided into a training set and a test set in a 7:3 ratio. Clinical data were collected, and univariate analysis was performed to identify important data significantly associated with the stone-free rate after PCNL. Three ML models (GBDT, RF, and XGBoost) were developed using the training set. The predictive performance of these models was evaluated using the area under the curve (AUC) of the receiver operating characteristic (ROC) on the test set, confusion matrix, specificity, sensitivity, accuracy, and F1 score. For the top-performing prediction model, the study further employed the SHapley Additive exPlanations (SHAP) method to enhance model interpretability by elucidating the contribution of individual features to the prediction outcomes and ranking the relative importance of the predictive data. Finally, the clinical utility of the model was assessed through decision curve analysis (DCA), which quantified the net clinical benefit of applying the model across various risk thresholds. Results: Postoperative statistics indicated a stone-free rate of 70.6% ( Conclusion: The prediction models developed based on three machine learning algorithms can accurately predict the stone-free rate after PCNL in patients with urinary tract stones. Among these, the GBDT model can effectively identify patients who are most likely to achieve successful outcomes from PCNL based on demographic and stone characteristics, thereby assisting in clinical treatment decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.